Skip to main content
Press Release

Stamford Nurse Admits Stealing and Tampering with Hydromorphone and Fentanyl Vials

For Immediate Release
U.S. Attorney's Office, District of Connecticut

Marc H. Silverman, Acting United States Attorney for the District of Connecticut, Fernando McMillan, Special Agent in Charge of the Food and Drug Administration, Office of Criminal Investigations New York Field Office, and Stephen P. Belleau, Acting Special Agent in Charge of the Drug Enforcement Administration for New England, announced that KRISTEN CAROTENUTO, 35, of Pelham, New York, waived her right to be indicted and pleaded guilty today before U.S. District Judge Vernon D. Oliver in Hartford to tampering with vials of hydromorphone and fentanyl at a surgical clinic in Stamford where she was employed as a nurse.

According to court documents and statements made in court, Carotenuto was employed as a nurse at an outpatient surgical center in Stamford.  As part of her employment, she was granted access to a secure location used by the surgical center to store controlled substances, including hydromorphone and fentanyl.  In December 2024, Carotenuto removed several vials, each containing hydromorphone or fentanyl, from the secure storage area.  She then took the vials home, removed the controlled substances using a syringe, and used the drugs.  She then refilled the vials with either saline or water and returned the tampered vials to the storage area in a location where they could be distributed for patient use.

Carotenuto pleaded guilty to tampering with a consumer product, an offense that carries a maximum term of imprisonment of 10 years.  Judge Oliver scheduled sentencing for June 30.

Carotenuto is released on a $25,000 bond pending sentencing.  She has surrendered her nursing license.

This matter is being investigated by the Food and Drug Administration, Office of Criminal Investigations; the DEA’s Hartford Diversion Control Division; and the Connecticut Department of Consumer Protection, Drug Control Division.  The case is being prosecuted by Assistant U.S. Attorney Ray Miller.

Updated April 7, 2025

Topics
Consumer Protection
Prescription Drugs